Addressing the key challenges for drug safety professionals

The regulatory environment is fast changing and the drug safety industry is facing significant hurdles in implementing standards globally. It is becoming increasingly challenging to meet all regulatory requirements effectively in the current globalised marketplace. Stay on top of pharmacovigilance requirements with updates directly from the regulators, agencies and industry who will show you how to implement regulatory standards globally. Learn …

Earlier Access to Medicines- Update on EAMS scheme

Dr Daniel O’Connor, MHRA joined us at the 9th Annual World Stem Cells & Regenerative Medicine Congress to present on ‘Earlier Access to Medicines –Early Access to Medicines Scheme and Adaptive Licensing pilot.’ Download this presentation to find out more about: What is EAMS? EAMS Milestones Role of the Ministerial Industry Strategy Group (MISG) Early Access to Medicines Launch Adaptive …